Featured Firms
Presented by BigVoodoo
The U.S. Court of Appeals for the Federal Circuit has confirmed a Southern District of New York ruling prohibiting the holder of the OxyContin patent from pursuing an infringement claim against a generic manufacturer. The appellate panel found that the patents held by the plaintiff, Purdue Pharma, were unenforceable because the company had misled the U.S. Patent and Trademark Office during its application.
June 10, 2005 at 12:00 AM
1 minute read
The original version of this story was published on Law.Com
Presented by BigVoodoo
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
Consulting Magazine recognizes leaders in technology across three categories Leadership, Client Service and Innovation.
Celebrate outstanding achievement in law firms, chambers, in-house legal departments and alternative business structures.
Health Law Associate CT Shipman is seeking an associate to join our national longstanding health law practice. Candidates must have t...
Shipman & Goodwin LLP is seeking two associates to expand our national commercial real estate lending practice. Candidates should have ...
Duane Morris LLP has an immediate opening for a senior level, highly motivated litigation associate to join its dynamic and growing Employme...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS